Early research (Phase 1)Study completedNCT04396717What this trial is testingSafety Study of Pritumumab in Brain CancerWho this might be right forMalignant Primary Brain TumorsBrain Metastases, Adult Nascent Biotech 15
Not applicableStudy completedNCT04252846What this trial is testingInvestigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized EpilepsyWho this might be right forIdiopathic Generalized EpilepsyPartial Onset SeizuresGeneralised Tonic-Clonic Seizures Eisai Limited 191
Not applicableLooking for participantsNCT06358625What this trial is testingIdentification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast CancerWho this might be right forHER2-positive Breast Cancer Center Eugene Marquis 120
Not applicableLooking for participantsNCT05033691What this trial is testingEvaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain MetastasesWho this might be right forNSCLCEGFR Gene MutationEGF-R Positive Non-Small Cell Lung Cancer+2 more Hadassah Medical Organization 162
Not applicableLooking for participantsNCT07222618What this trial is testing"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MSWho this might be right forMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+3 more University of California, San Francisco 300
Large-scale testing (Phase 3)Looking for participantsNCT05768490What this trial is testingEarly or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain MetastasesWho this might be right forBrain MetastasesRadiotherapyEGFR Activating Mutation Sun Yat-sen University 232
Early research (Phase 1)Active Not RecruitingNCT02191488What this trial is testingALA-induced PpIX Fluorescence During Brain Tumor ResectionWho this might be right forBrain Tumors David W. Roberts 540
Early research (Phase 1)Study completedNCT00006246What this trial is testingBusulfan in Treating Children and Adolescents With Refractory CNS CancerWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more Pediatric Brain Tumor Consortium 28
Testing effectiveness (Phase 2)UnknownNCT04211090What this trial is testingCamrelizumab With AC in Patients With Brain Metastases of Driven Gene-negative,NSCLCWho this might be right forNon-squamous Non-small-cell Lung CancerBrain Metastases Sun Yat-sen University 45
Testing effectiveness (Phase 2)Ended earlyNCT04461418What this trial is testingAccelerated Checkpoint Therapy for Any Steroid Dependent Patient With Brain MetastasesWho this might be right forBrain Metastases, Adult AHS Cancer Control Alberta 2
Testing effectiveness (Phase 2)UnknownNCT05398224What this trial is testingR-MTX-zanbrutinib in Secondary CNS LymphomaWho this might be right forSecondary Central Nervous System Lymphoma Peking University 45
Very early researchUnknownNCT06489925What this trial is testingCerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery OcclusionWho this might be right forBasilar Artery OcclusionPosterior Circulation Brain Infarction University Hospital Sestre Milosrdnice 20
Not applicableStudy completedNCT00795678What this trial is testingChemotherapeutic Agents in Brain/BreastWho this might be right forBreast CancerMetastatic Cancer Case Comprehensive Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT05289908What this trial is testingIntrathecal Pemetrexed for Leptomeningeal MetastasisWho this might be right forLeptomeningeal Metastases The First Hospital of Jilin University 34
Testing effectiveness (Phase 2)Looking for participantsNCT04899908What this trial is testingStereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain MetastasesWho this might be right forBrain CancerBrain MetastasesMelanoma+13 more Brigham and Women's Hospital 134
Early research (Phase 1)Ended earlyNCT00004058What this trial is testing12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow DisorderWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more University of Medicine and Dentistry of New Jersey
Testing effectiveness (Phase 2)Study completedNCT01789255What this trial is testingVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+115 more National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT02662725What this trial is testingIpilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain MetastasesWho this might be right forMelanomaBrain Metastasis University Hospital, Lille 73
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07177950What this trial is testingA Two-cohort Study of SHR-A1811 in the Treatment of HER2-positive Breast Cancer With Brain MetastasesWho this might be right forBreast CancerBrain MetastasesLeptomeningeal Metastasis Peking University Cancer Hospital & Institute 51
Testing effectiveness (Phase 2)Study completedNCT02048059What this trial is testingANG1005 in Breast Cancer Patients With Recurrent Brain MetastasesWho this might be right forBreast CancerBrain Metastases Angiochem Inc 72